Kerri-Ann Millar
2023
In 2023, Kerri-Ann Millar earned a total compensation of $1.2M as Chief Financial Officer at Cue Biopharma, a 10% increase compared to previous year.
Compensation breakdown
| Option Awards | $715,201 |
|---|---|
| Salary | $444,181 |
| Other | $3,156 |
| Total | $1,162,538 |
Millar received $715.2K in option awards, accounting for 62% of the total pay in 2023.
Millar also received $444.2K in salary and $3.2K in other compensation.
Rankings
In 2023, Kerri-Ann Millar's compensation ranked 1,046th out of 2,978 executives tracked by ExecPay. In other words, Millar earned more than 64.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,046 out of 2,978 | 65th |
Division Manufacturing | 621 out of 1,637 | 62nd |
Major group Chemicals And Allied Products | 427 out of 906 | 53rd |
Industry group Drugs | 416 out of 869 | 52nd |
Industry Pharmaceutical Preparations | 284 out of 627 | 55th |
Source: SEC filing on April 26, 2024.
Millar's colleagues
We found two more compensation records of executives who worked with Kerri-Ann Millar at Cue Biopharma in 2023.